Saccharomyces Cerevisiae|Journals Open Access|Saccharomyces Cerevisiae

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Saccharomyces Cerevisiae

"The molecular display method to prepare target proteins is especially well established for use with the yeast Saccharomyces cerevisiae , and it is also known as “cell surface engineering”. For example, an antigen from red sea bream iridovirus (RSIV) was displayed on the surface of yeast cells to create an oral vaccine for use in fisheries. ß-glucan, an abundant component 1 of the yeast cell wall, is thought to function as an adjuvant. Further, yeast is a generally recognized as safe (GRAS) organism, suitable for the preparation of oral vaccines without antigen purification, while that process is required for recombinant proteins produced by E. coli . Therefore, molecular display could provide a method for production of antigenic proteins selected in proteome studies that is more rapid and convenient than conventional vaccine production methods. OMICS Group International is one of the leading Open Access Publishers which is publishing 700+ peer-reviewed journals with the support of 50,000+ editorial board members as editorial team and aimed to disseminate the scholarly knowledge to the scientific society. OMICS Group also organizing 3000+ International Scientific Conferences and events yearly all over the world with the support of 1000+ Scientific associations worldwide. Citation: Shibasaki S, Karasaki M, Ueda M (2014) Combining Proteomic Strategies and Molecular Display Technology for Development of Vaccines against Candida albicans. J Proteomics Bioinform 7: 134-138."
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on January, 2021